BioCardia, Inc.
BCDA
$0.82
-$0.06-6.50%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -19.28% | -20.28% | 0.54% | 71.00% | 23.29% |
| Gross Profit | 19.28% | 20.28% | -0.54% | -71.64% | -29.01% |
| SG&A Expenses | -13.80% | -2.32% | -33.09% | -19.84% | 9.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.87% | -13.27% | -15.26% | 24.15% | 17.00% |
| Operating Income | 16.87% | 13.27% | 15.26% | -24.38% | -19.82% |
| Income Before Tax | 16.70% | 13.59% | 14.62% | -24.48% | -19.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.70% | 13.59% | 14.62% | -24.48% | -19.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.70% | 13.59% | 14.62% | -24.48% | -19.63% |
| EBIT | 16.87% | 13.27% | 15.26% | -24.38% | -19.82% |
| EBITDA | 16.62% | 12.84% | 14.71% | -25.37% | -20.30% |
| EPS Basic | 64.29% | 62.88% | 61.55% | 53.81% | 56.76% |
| Normalized Basic EPS | 64.28% | 62.88% | 61.56% | 53.82% | 56.76% |
| EPS Diluted | 64.29% | 62.88% | 61.55% | 53.81% | 56.76% |
| Normalized Diluted EPS | 64.28% | 62.88% | 61.56% | 53.82% | 56.76% |
| Average Basic Shares Outstanding | 133.24% | 132.73% | 122.03% | 169.55% | 176.68% |
| Average Diluted Shares Outstanding | 133.24% | 132.73% | 122.03% | 169.55% | 176.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |